Literature DB >> 32467190

COVID-19-Associated Miller Fisher Syndrome: MRI Findings.

J E Lantos1, S B Strauss2, E Lin2.   

Abstract

Miller Fisher syndrome, also known as Miller Fisher variant of Guillain-Barré syndrome, is an acute peripheral neuropathy that can develop after exposure to various viral, bacterial, and fungal pathogens. It is characterized by a triad of ophthalmoplegia, ataxia, and areflexia. Miller Fisher syndrome has recently been described in the clinical setting of the novel coronavirus disease 2019 (COVID-19) without accompanying imaging. In this case, we report the first presumptive case of COVID-19-associated Miller Fisher syndrome with MR imaging findings.
© 2020 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2020        PMID: 32467190      PMCID: PMC7357656          DOI: 10.3174/ajnr.A6609

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  10 in total

1.  Clinical features and prognosis of Miller Fisher syndrome.

Authors:  M Mori; S Kuwabara; T Fukutake; N Yuki; T Hattori
Journal:  Neurology       Date:  2001-04-24       Impact factor: 9.910

2.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.

Authors:  Ling Mao; Huijuan Jin; Mengdie Wang; Yu Hu; Shengcai Chen; Quanwei He; Jiang Chang; Candong Hong; Yifan Zhou; David Wang; Xiaoping Miao; Yanan Li; Bo Hu
Journal:  JAMA Neurol       Date:  2020-06-01       Impact factor: 18.302

3.  Miller Fisher syndrome and polyneuritis cranialis in COVID-19.

Authors:  Consuelo Gutiérrez-Ortiz; Antonio Méndez-Guerrero; Sara Rodrigo-Rey; Eduardo San Pedro-Murillo; Laura Bermejo-Guerrero; Ricardo Gordo-Mañas; Fernando de Aragón-Gómez; Julián Benito-León
Journal:  Neurology       Date:  2020-04-17       Impact factor: 9.910

Review 4.  The Fisher variant of Guillain-Barré syndrome (Fisher syndrome).

Authors:  Lee A Snyder; Vivian Rismondo; Neil R Miller
Journal:  J Neuroophthalmol       Date:  2009-12       Impact factor: 3.042

5.  Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination.

Authors:  Y Nishimoto; M Odaka; K Hirata; N Yuki
Journal:  J Neuroimmunol       Date:  2004-03       Impact factor: 3.478

6.  A Case of Miller Fisher Syndrome and Literature Review.

Authors:  Sumera Bukhari; Javier Taboada
Journal:  Cureus       Date:  2017-02-22

Review 7.  Miller Fisher syndrome developing as a parainfectious manifestation of dengue fever: a case report and review of the literature.

Authors:  Nipun Lakshitha de Silva; Praveen Weeratunga; Thirugnanam Umapathi; Neelika Malavige; Thashi Chang
Journal:  J Med Case Rep       Date:  2019-05-02

8.  Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy.

Authors:  Asia Filatov; Pamraj Sharma; Fawzi Hindi; Patricio S Espinosa
Journal:  Cureus       Date:  2020-03-21

9.  Neurotropism of SARS-CoV 2: Mechanisms and manifestations.

Authors:  Giancarlos Conde Cardona; Loraine D Quintana Pájaro; Iván D Quintero Marzola; Yancarlos Ramos Villegas; Luis R Moscote Salazar
Journal:  J Neurol Sci       Date:  2020-04-08       Impact factor: 3.181

10.  COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features.

Authors:  Neo Poyiadji; Gassan Shahin; Daniel Noujaim; Michael Stone; Suresh Patel; Brent Griffith
Journal:  Radiology       Date:  2020-03-31       Impact factor: 11.105

  10 in total
  34 in total

1.  COVID-19 Presenting As Miller Fisher Syndrome in a Patient With a History of Guillain-Barré Syndrome: A Case Report.

Authors:  Louay Aldabain; Metri Haddaden; Rehan Farooqi; Malaz Alissa
Journal:  Cureus       Date:  2022-07-05

Review 2.  The Immediate Onset of Isolated and Unilateral Abducens Nerve Palsy Associated with COVID-19 Infection: A Case Report and Literature Review.

Authors:  Takafumi Kubota; Naoto Sugeno; Hirohito Sano; Koji Murakami; Kensuke Ikeda; Tatsuro Misu; Masashi Aoki
Journal:  Intern Med       Date:  2022-06-01       Impact factor: 1.282

3.  Brain Imaging of Patients with COVID-19: Findings at an Academic Institution during the Height of the Outbreak in New York City.

Authors:  E Lin; J E Lantos; S B Strauss; C D Phillips; T R Campion; B B Navi; N S Parikh; A E Merkler; S Mir; C Zhang; H Kamel; M Cusick; P Goyal; A Gupta
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-20       Impact factor: 3.825

Review 4.  Ocular Manifestations of Patients with Coronavirus Disease 2019: A Comprehensive Review.

Authors:  Amirhossein Roshanshad; Mohammad Ali Ashraf; Romina Roshanshad; Ali Kharmandar; Seyed Alireza Zomorodian; Hossein Ashraf
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29

5.  COVID-19 Induced Miller Fisher Syndrome Presenting With Autonomic Dysfunction: A Unique Case Report and Review of Literature.

Authors:  Subhrajyoti Biswas; Ritwik Ghosh; Arpan Mandal; Alak Pandit; Dipayan Roy; Samya Sengupta; Kaustav De; Bikash Chandra Swaika; Julián Benito-León
Journal:  Neurohospitalist       Date:  2021-05-17

Review 6.  COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.

Authors:  Arens Taga; Giuseppe Lauria
Journal:  J Peripher Nerv Syst       Date:  2022-03-14       Impact factor: 5.188

7.  Guillain Barré syndrome associated with COVID-19- lessons learned about its pathogenesis during the first year of the pandemic, a systematic review.

Authors:  Mayka Freire; Ariadna Andrade; Bernardo Sopeña; Maria Lopez-Rodriguez; Pablo Varela; Purificación Cacabelos; Helena Esteban; Arturo González-Quintela
Journal:  Autoimmun Rev       Date:  2021-06-10       Impact factor: 9.754

8.  SARS-CoV-2 associated Miller-Fisher syndrome or polyneuritis cranialis.

Authors:  Josef Finsterer
Journal:  Environ Sci Pollut Res Int       Date:  2021-06-11       Impact factor: 5.190

Review 9.  New-Onset Movement Disorders Associated with COVID-19.

Authors:  Pedro Renato P Brandão; Talyta C Grippe; Danilo A Pereira; Renato P Munhoz; Francisco Cardoso
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-07-08

10.  Neuroradiological Features of Mild and Severe SARS-CoV-2 Infection.

Authors:  Simon Pan; Willam C Chen; Joe D Baal; Leo P Sugrue
Journal:  Acad Radiol       Date:  2020-08-29       Impact factor: 3.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.